Buch, Englisch, 289 Seiten, Paperback, Format (B × H): 178 mm x 254 mm, Gewicht: 569 g
Buch, Englisch, 289 Seiten, Paperback, Format (B × H): 178 mm x 254 mm, Gewicht: 569 g
Reihe: Methods in Pharmacology and Toxicology
ISBN: 978-1-4939-8078-9
Verlag: Springer
that explore the current status of immunotherapy and diagnostic markers for
neurodegenerative disorders. With a focus on Alzheimer’s disease, the first
sections of the book examine immunotherapeutic approaches for the
aforementioned disease as well as for Parkinson’s disease and Huntington’s disease,
amongst others. The last section of the book covers the importance of biomarker
techniques to catch these diseases early enough for the treatments to be most
useful. Written for the Methods in
Pharmacology and Toxicology series, this book contains the kind of detailed
descriptions and implementation advice that will offer a smooth transition into
the lab.
Authoritative and useful, Immunotherapy and Biomarkers in
Neurodegenerative Disorders aims to aid in the continued progress in the
development of novel immune-based drugs and diagnostic tools for these
devastating brain diseases.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
Weitere Infos & Material
Part I: Immunotherapy
Against Amyloid-b in
Alzheimer’s Disease
1. Immunotherapy Against Amyloid-ß in Alzheimer’s Disease: An Overview
Niels D. Prins
2. Active Immunization Against the
Amyloid-ß Peptide
Enchi Liu
and J. Michael Ryan
3. Immunotherapy
Against N-Truncated Amyloid-ß Oligomers
Thomas A.
Bayer and Oliver Wirths
4. Immunotherapy
Against Amyloid-ß Protofibrils: Opportunities and Challenges
Lars
Lannfelt
Part II:
Immunotherapy in Other Neurodegenerative Disorders
5. Immunotherapy
Against a-Synuclein Pathology
Elvira
Valera and Eliezer Masliah
6. Extracellular a-Synuclein as a Target for
Immunotherapy
Jun Sung Lee and Seung-Jae Lee
7. Immunotherapy of Parkinson’s Disease
Achim Schneeberger,
Suzanne Hendrix, and Markus Mandler
8. Tau Immunotherapy
Einar M. Sigurdsson
9. Active and Passive Immunotherapy Against Tau: Effects and
Potential Mechanisms
Kiran Yanamandra, Marc
I. Diamond, and David M. Holtzman
10. Immunotherapy on Experimental Models for
Huntington’s Disease